Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03062657 · ClinicalTrials.gov registry record · NA
An Investigation of the Metal Concentration in Patients Implanted With the PRESTIGE LP™ Cervical Disc at Two Contiguous Levels in the Cervical Spine
A NA study, sponsored by Medtronic Spinal and Biologics.
- Terminated
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03062657 is a NA study that was terminated before completion, run by Medtronic Spinal and Biologics. The registered enrollment target is 25 participants.
The verdict
NCT03062657, a NA study, was terminated before completion, sponsored by Medtronic Spinal and Biologics.
- TERMINATED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This clinical study will assess the metal concentrations present in the blood serum of patients who receive surgical treatment with the PRESTIGE LP™ Cervical Disc at two contiguous cervical levels from C3-C7. The information obtained from this clinical investigation will be used to support the post market surveillance for a PMA supplement for the PRESTIGE LP™ Cervical Disc implanted at two contiguous levels.
Interventions
- DEVICE PRESTIGE LP™ Cervical Disc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-06-06 |
| Est. Completion | 2023-01-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03062657
The ClinicalTrials.gov registry entry for NCT03062657 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Spinal and Biologics, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PRESTIGE LP™ Cervical Disc is the first listed.
NCT03062657 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03062657 about?
NCT03062657 is a clinical study titled "An Investigation of the Metal Concentration in Patients Implanted With the PRESTIGE LP™ Cervical Disc at Two Contiguous Levels in the Cervical Spine". This clinical study will assess the metal concentrations present in the blood serum of patients who receive surgical treatment with the PRESTIGE LP™ Cervical Disc at two contiguous cervical levels from C3-C7. The information obtained from this clinical investigation will be used to support the post ...
What is the current status of trial NCT03062657?
This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2018-06-06. Estimated completion is 2023-01-27.
What interventions are being tested in trial NCT03062657?
The interventions under investigation include: PRESTIGE LP™ Cervical Disc (DEVICE).
Who is sponsoring clinical trial NCT03062657?
This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.